Christopher Peetz - 02 Feb 2026 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
02 Feb 2026
Net transactions value
-$940,888
Form type
4
Filing time
03 Feb 2026, 21:45:07 UTC
Previous filing
30 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Peetz Christopher CHIEF EXECUTIVE OFFICER, Director C/O MIRUM PHARMACEUTICALS, INC., 989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY /s/ Judit Ryvkin, Attorney-in-Fact 03 Feb 2026 0001614740

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale $940,888 -9,108 -5.4% $103.30 160,294 02 Feb 2026 Direct F1
holding MIRM Common Stock 187,500 02 Feb 2026 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.